S Schneeweiss, M Maclure, AM Walker, P Grootendorst… - Health Policy, 2001 - Elsevier

On the evaluation of drug benefits policy changes with longitudinal claims data: the policy maker's versus the clinician's perspective.

quasi-experimental designs

Schneeweiss, Walker

GSID: GTSm_JIfyLkJ

Excerpt

Cost containment in pharmaceutical-benefit plans are often controversially debated for their potential of unintended consequences on health and overall expenditures. Thorough …